Mimedx (MDXG) Share-based Compensation (2011 - 2026)
Mimedx recorded quarterly Share-based Compensation of -$1.7 million in Q1 2026, down 168.86% quarter-over-quarter from $2.5 million in Q4 2025, and down 139.79% year-over-year from $4.3 million in Q1 2025.
Mimedx's Share-based Compensation history runs 16 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- In Q1 2026, Share-based Compensation fell 139.79% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at $10.4 million (down 38.07% YoY), while the FY2025 annual figure was $16.4 million, down 3.17% from the prior year.
- Share-based Compensation came in at -$1.7 million for Q1 2026 at Mimedx, down from $2.5 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $4.9 million in Q3 2025 to a low of -$1.7 million in Q1 2026.
- A 5-year average of $3.5 million and a median of $4.1 million in 2024 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation jumped 727.55% in 2023 and slumped 139.79% in 2026, its largest moves.
- Mimedx's Share-based Compensation stood at $530000.0 in 2022, then surged by 727.55% to $4.4 million in 2023, then rose by 7.0% to $4.7 million in 2024, then tumbled by 47.52% to $2.5 million in 2025, then tumbled by 168.86% to -$1.7 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered -$1.7 million, $2.5 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.70 Mn |
| Mar 31, 2026 | -1.70 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Sep 30, 2025 | 4.92 Mn |
| Sep 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | 4.75 Mn |
| Jun 30, 2025 | 4.75 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.81 Mn |
| Jun 30, 2024 | 4.09 Mn |
| Jun 30, 2024 | 4.09 Mn |
| Mar 31, 2024 | 4.34 Mn |
| Mar 31, 2024 | 4.34 Mn |
| Dec 31, 2023 | 4.39 Mn |
| Dec 31, 2023 | 4.39 Mn |
| Sep 30, 2023 | 4.39 Mn |
| Sep 30, 2023 | 4.39 Mn |
| Jun 30, 2023 | 4.06 Mn |
| Jun 30, 2023 | 4.06 Mn |
| Mar 31, 2023 | 3.90 Mn |
| Mar 31, 2023 | 3.90 Mn |
| Dec 31, 2022 | 530,000.00 |
| Dec 31, 2022 | 530,000.00 |
| Sep 30, 2022 | 2.37 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | 4.43 Mn |
| Jun 30, 2022 | 4.43 Mn |
| Mar 31, 2022 | 4.00 Mn |
| Mar 31, 2022 | 4.00 Mn |
| Dec 31, 2021 | 3.04 Mn |
| Dec 31, 2021 | 3.04 Mn |
| Sep 30, 2021 | 3.81 Mn |
| Sep 30, 2021 | 3.81 Mn |
| Jun 30, 2021 | 4.06 Mn |
| Jun 30, 2021 | 4.06 Mn |
| Mar 31, 2021 | 3.24 Mn |
| Mar 31, 2021 | 3.24 Mn |
| Dec 31, 2020 | 3.91 Mn |
| Dec 31, 2020 | 3.91 Mn |
| Sep 30, 2020 | 3.67 Mn |
| Sep 30, 2020 | 3.67 Mn |
| Jun 30, 2020 | 4.43 Mn |
| Jun 30, 2020 | 4.43 Mn |
| Mar 31, 2020 | 3.35 Mn |
| Mar 31, 2020 | 3.35 Mn |
| Dec 31, 2019 | 2.87 Mn |
| Dec 31, 2019 | 2.87 Mn |
| Sep 30, 2019 | 2.69 Mn |
| Sep 30, 2019 | 2.69 Mn |
| Jun 30, 2019 | 3.50 Mn |
| Jun 30, 2019 | 3.50 Mn |
| Mar 31, 2019 | 3.01 Mn |
| Mar 31, 2019 | 3.01 Mn |
| Dec 31, 2018 | 1.46 Mn |
| Dec 31, 2018 | 1.46 Mn |
| Sep 30, 2018 | 3.96 Mn |
| Sep 30, 2018 | 3.96 Mn |
| Jun 30, 2018 | 4.42 Mn |
| Jun 30, 2018 | 4.42 Mn |
| Mar 31, 2018 | 4.93 Mn |
| Mar 31, 2018 | 4.93 Mn |
| Dec 31, 2017 | 5.96 Mn |
| Dec 31, 2017 | 5.96 Mn |
| Sep 30, 2017 | 5.31 Mn |
| Sep 30, 2017 | 5.31 Mn |
| Jun 30, 2017 | 5.26 Mn |
| Jun 30, 2017 | 5.26 Mn |
| Mar 31, 2017 | 4.67 Mn |
| Mar 31, 2017 | 4.67 Mn |
| Dec 31, 2016 | 3.91 Mn |
| Dec 31, 2016 | 3.91 Mn |
| Sep 30, 2016 | 4.70 Mn |
| Sep 30, 2016 | 4.70 Mn |
| Jun 30, 2016 | 4.51 Mn |
| Jun 30, 2016 | 4.51 Mn |
| Mar 31, 2016 | 4.62 Mn |
| Mar 31, 2016 | 4.62 Mn |
| Dec 31, 2015 | 4.33 Mn |
| Dec 31, 2015 | 4.33 Mn |
| Sep 30, 2015 | 4.38 Mn |
| Sep 30, 2015 | 4.38 Mn |
| Jun 30, 2015 | 4.25 Mn |
| Jun 30, 2015 | 4.25 Mn |
| Mar 31, 2015 | 3.93 Mn |
| Mar 31, 2015 | 3.93 Mn |
| Dec 31, 2014 | 3.29 Mn |
| Dec 31, 2014 | 3.29 Mn |
| Sep 30, 2014 | 3.02 Mn |
| Sep 30, 2014 | 3.02 Mn |
| Jun 30, 2014 | 2.77 Mn |
| Jun 30, 2014 | 2.77 Mn |
| Mar 31, 2014 | 2.37 Mn |
| Mar 31, 2014 | 2.37 Mn |
| Dec 31, 2013 | 1.85 Mn |
| Dec 31, 2013 | 1.85 Mn |
| Sep 30, 2013 | 1.67 Mn |
| Sep 30, 2013 | 1.67 Mn |
| Jun 30, 2013 | 1.50 Mn |
| Jun 30, 2013 | 1.50 Mn |
| Mar 31, 2013 | 984,792.00 |
| Mar 31, 2013 | 984,792.00 |
| Dec 31, 2012 | 783,331.00 |
| Dec 31, 2012 | 783,331.00 |
| Sep 30, 2012 | 669,469.00 |
| Sep 30, 2012 | 669,469.00 |
| Jun 30, 2012 | 585,215.00 |
| Jun 30, 2012 | 585,215.00 |
| Mar 31, 2012 | 500,985.00 |
| Mar 31, 2012 | 500,985.00 |
| Dec 31, 2011 | 626,822.00 |
| Dec 31, 2011 | 626,822.00 |
| Sep 30, 2011 | 222,792.00 |
| Sep 30, 2011 | 222,792.00 |
| Jun 30, 2011 | 429,096.00 |
| Jun 30, 2011 | 429,096.00 |
| Mar 31, 2011 | 380,373.00 |
| Mar 31, 2011 | 380,373.00 |